- This event has passed.
Taking health up a gear: value of advanced therapies
11 May 2021 @ 12:00 pm – 1:00 pm CEST
Advanced therapies have ground-breaking therapeutic potential, particularly in disease areas where there is an unmet medical need and available therapeutic options are absent or inadequate. These therapies can bring the possibility of a cure to life-threatening conditions with a one-off treatment, thereby changing the paradigm of providing health and care to patients suffering serious, rare or complex diseases.
A breakthrough innovator in the area of rare diseases will explain the cutting-edge science behind gene therapies, why they are considered so transformative, and what promise they hold to addressing unmet patient needs.
A leading developer of the most innovative cancer treatments – CAR-T cell-based therapies will explain the changing paradigm of providing health for cancer patients and how innovation will help achieve the objectives of Europe’s Beating Cancer Plan.
The webinar will also engage policy makers reflecting live on how EU policies can truly harness the ground-breaking potential of advanced therapies.
Speakers
Sara Cerdas MEP, BECA
Dick Sundh, Head of ACE (Australia, Canada & Europe) at Kite Pharma, a Gilead Company
Dirk Vander Mijnsbrugge, Vice President Medical Affairs Lead Rare Diseases International Developed Markets at Pfizer
Simone Boselli, Public Affairs Director at EURORDIS
About EuropaBio Advanced Therapies Series:
The EuropaBio Advanced Therapies series of events, interviews, and publications will engage policymakers, regulators, patients and their representatives, developers, and all relevant stakeholders to discuss how innovation in gene- and cell-based medicine can bring a transformative value for patients.
Throughout 2021, we invite you to join us on a journey of exploring the tremendous potential of advanced therapies by discussing the new treatment paradigms, the future of research and development in this fast-moving space of bio-science, as well as debating recommendations for improving the access of patients to these ground-breaking treatments and supporting advanced manufacturing, to name a few.
VIRTUAL EVENT